2024 health insurer CEO pay ratios reveal top executives earning up to 370 times median staff. Medicare Advantage costs remain elevated but manageable as per insurers' financial disclosures.
Explore critical U.S. public health and policy updates affecting healthcare insurance, including COVID-19 booster guidance, AI diagnostics, Medicare Advantage reforms, and expanding HIV challenges in Texas.
Medicare beneficiaries face higher costs as Part D plans shift from fixed co-pays to coinsurance for expensive Tier 3 drugs, raising out-of-pocket expenses significantly.
UnitedHealth Group reports significant OptumHealth underperformance driven by higher Medicare Advantage utilization and risk adjustment challenges, raising profitability concerns and prompting strategic prioritization of patient engagement.
Medicare Part D stand-alone prescription drug plans serve a majority of rural Medicare beneficiaries, with premium stabilization efforts influencing plan availability and affordability in 2025 and beyond.
UnitedHealth Group lowers its 2025 revenue forecast due to increased Medicare Advantage plan usage, signaling shifts in health insurance market trends and consumer preferences.
CMS finalizes key aspects of the 2026 Medicare Advantage and Part D programs rule, including expanded insulin coverage, payment plans, and new pharmacy requirements for network participation.
Elevance Health lowers full-year profit forecast despite Q1 revenue growth driven by higher premiums and membership gains in Medicare Advantage and ACA.
Elevance Health reports 15% revenue growth in Q1 2025 driven by Medicare Advantage expansion, premium increases, and CarelonRx portfolio growth, highlighting ongoing healthcare market evolution.
President Trump's executive order prompts potential changes in Medicare drug price negotiation, affecting pharmaceutical pricing, Medicare spending, and FDA drug import regulations. Epic Systems also shifts to a more public presence in healthcare IT.
